Monographie - Omeprazole sodium

Poslední aktualizace :
08/05/2024

Omeprazole sodium

Cheminė sandara

Prekinis pavadinimas

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Antra	Italija, Šveicarija, Vokietija
Biomezol	Ekvadoras
Cezole	Peru
Ciplaprazole	Kolumbija
Dinsadrix	Meksikas
Fendiprazole	Argentina
Finulcer	Meksikas
Fordex	Venesuela
Gaspiren	Brazilija
Gastromax	Venesuela
Gerdex	Meksikas
Haitrax	Meksikas
Helicid	Lenkija
Imaroz	Čilė
Inhibitron	Meksikas
Ipproton	Saudo Arabija, Tunisas
Klomeprax	Argentina, Ekvadoras
Lordin	Graikija
Losec	Austrija, Belgija, Didžioji Britanija, Italija, Lenkija, Olandija, Saudo Arabija, Turkija
Mepral	Italija
Omeprazen	Italija
Omeprazol	Vokietija
Omeprazole	Prancūzija
Oprazole	Saudo Arabija
Penrazol	Graikija
Rizek	Saudo Arabija
Timezol	Argentina
Ulcozol	Argentina
Ultop	Kroatija

Bibliografija : Omeprazole sodium

	Tipas	Leidinys
186	Žurnalas	Swart EL, Mooren RAG, Van Loenen AC. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1995 ; 52: 2020-2022.
264	Žurnalas	Leboucher G, Charpiat B. Incompatibilité physico-chimique entre l’oméprazole et la vancomycine. Pharm Hosp Fr 1997 ; 121: 124.
1703	Žurnalas	Schuster F, Bernard R. Kompatibilität von enalaprilat i.v. mit ausgewählten arzneimitteln. Krankenhauspharmazie 1995 ; 16: 101-103.
2231	Žurnalas	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2311	Žurnalas	Kambia N.K, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Nefopam hydrochloride compatibility and stability with selected proton pump inhibitors in bionolyte G5 injection for intravenous infusion. J Clin Pharm Ther 2009 ; 34: 25-31.
3332	Laboratorija	Tigecycline (Tigacyl®) - Summary of Product characteristics Pfizer 2012
3658	Laboratorija	Omeprazole - Summary of Product Characteristics. Sandoz 2014
3823	Žurnalas	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3871	Plakatas	Soussi M.A, Soualah-alila R, jenene F, Lazreg O, Razgallah Khrouf M. Peut-on administrer le céfotaxime en Y avec d'autres médicaments injectables ? Synprefh Congress Clermont Ferrand, France 2016
3976	Žurnalas	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	Plakatas	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4316	Žurnalas	Carpenter J.F, McNulty M-A, Dusci L.J, Ilett K.F. Stability of Omeprazole Sodium and Pantoprazole Sodium Diluted for Intravenous Infusion. J Pharm Technol 2006 ;22:95-98.
4642	Plakatas	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021

Mentions Légales